CBLT Enters LOI to Buy 70% of Werner Lake and Updates Hemlo Operations

CBLT.v, gold

CBLT Inc. (TSXV: CBLT) (“CBLT“) announces it has entered into a Letter of Intent (the “LOI“) to buy the 70% majority interest in the Werner Lake Copper-Cobalt-Gold Project (“Werner Lake“) from Global Energy Metals Corporation (“GEMC“). Readers are directed to GEMC’s website for details and documents related to Werner Lake (https://www.globalenergymetals.com/projects/werner-lake-cobalt-project/). read more

Northstar Enlarges Kirkland Lake District Land Package

Cannot view this image? Visit: https://i0.wp.com/orders.newsfilecorp.com/files/6839/67254_4a936a4ac4a9292a_002.jpg?w=570&ssl=1

Northstar Gold Corp. (CSE: NSG) (“Northstar” or the “Company“) reports the Company has acquired by way of purchase agreement the Rosegrove Property, situated 16 km south of the town of Kirkland Lake and Kirkland Lake Gold’s Macassa SMC gold mine, and 1.5 kilometres northwest of Northstar’s flagship Miller Gold Property, where the Company recently completed a 5,023 metre, 28 hole diamond drill program targeting near-surface high-grade and bulk-tonnage gold-telluride mineralization. The purchase price is $10,000 (Cdn.) and the issuance of 50,000 common shares of Northstar. read more

Northstar Intersects 31.1 g/t Au Over 0.7m and 15.1 g/t Au Over 0.8m at Planet Syenite

info

Northstar Gold Corp. (CSE: NSG) (“Northstar” or the “Company“)reports drill results from the last 5 holes of a 5,023 metre, 28 hole Phase I diamond drill program on the Company’s 100%-owned Miller Gold Property, situated 18 km southeast of the town of Kirkland Lake and Kirkland Lake Gold’s Macassa SMC gold mine. read more

CBLT Inc: You can make more money with a pen than a drill

V.CBLT, CBLT Inc., gold, Ontario

There is no single right way to organize and operate a junior resource company. Instead, each company needs to figure out its own path to maximizing shareholder value. Whether it is a greenfields exploration story or a brownfields mining restart, every project is different. Peter Clausi, CEO of CBLT Inc. (V.CBLT), spent the early part of his career as a commercial litigation lawyer on Bay Street. He’s seen most of the business models. read more

CBLT Updates on Omni’s Progress at Northshore Gold

CBLT.v, gold

As previously announced on August 19, 2020, CBLT Inc. (TSXV: CBLT) (“CBLT“) closed the sale of its majority interest in the Northshore Gold Property Joint Venture (the “Property“) to Omni Commerce Corp. (“Omni“). CBLT was paid $350,000 in cash and $1,100,000 in common shares of Omni, which shares are subject to a regulatory four month hold and a voluntary escrow agreement providing for staggered releases over the next year. The first release from escrow of 25% of CBLT’s holdings will take place on or about December 20, 2020. read more

Renforth Identifies Surimeau Project, with ~19km Polymetallic Mineralized Trend

RFR.C, Renforth Resources, gold, Quebec

Renforth Resources Inc. (CSE:RFR)(OTC PINK:RFHRF)(WKN:A2H9TN) (“Renforth” or the “Company”) has completed our June field work successfully and is particularly impressed with the results of our initial prospecting work at Malartic West, results will be released as available. read more

FSD Pharma Reports Favorable Topline Results from Phase 1 First-in-Human Safety and Tolerability Study of Ultramicronized PEA

All subjects completed the trial per protocol, no safety concerns found up to the highest dose tested of 2400 mg/day
C.HUGE, FSD Pharma, cannabis, pot

FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today announced favorable topline results from its Phase 1 randomized, double-blind, placebo-controlled study of ultramicronized palmitoylethanolamide (PEA), or FSD201. This single-site study was conducted at the Alfred Hospital, part of the Alfred Health group of hospitals serving the state of Victoria in Australia and enrolled 48 healthy adult men and women. read more

FSD Pharma Announces Closing of C$10.125 Million Private Placement to Institutional Investors

C.HUGE, FSD Pharma, cannabis, pot

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (the “Company”) announces the closing of a previously announced private placement of 1,500,000 of the Company’s Class B Subordinate Voting Shares (“Shares”) at a price of C$6.75 per Share and warrants to purchase 1,500,000 Shares (cumulatively, the “Securities”) of the Company to certain institutional investors for gross proceeds, before deducting placement fees and other estimated offering expenses payable by the Company, of approximately C$10.125 million. The warrants have a five-year term and an exercise price of C$9.65 per share. read more

FSD Pharma Inc. Announces C$10.125 Million Private Placement

C.HUGE, FSD Pharma, cannabis, pot

FSD Pharma Inc. (NASDAQ: HUGE) CSE;HUGE or the “Company”), today announced it has entered into definitive agreements with certain institutional investors for the purchase and sale of 1,500,000 shares of the Company’s Class B Subordinate Voting Shares (“Shares”) at a price of C$6.75 per Share pursuant to a private placement resulting in gross proceeds of approximately C$10.125 million. The Company has also agreed to issue common share purchase warrants to purchase 1,500,000 Shares of the Company. The warrants will have a five year-term and an exercise price of C$9.65 per share. The closing of the offering is expected to occur on or about June 8, 2020, subject to the satisfaction of customary closing conditions including applicable exchange approvals.  The Company has granted the investors an option to acquire up to an additional C$10.125 million of units on the terms set forth above for a period of 30 days following the initial closing. read more